PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Geron Corporation (GERN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US3741631036

CUSIP

374163103

Sector

Healthcare

IPO Date

Jun 30, 1996

Highlights

Market Cap

$2.14B

EPS (TTM)

-$0.32

PEG Ratio

-2.38

Total Revenue (TTM)

$29.46M

Gross Profit (TTM)

$28.67M

EBITDA (TTM)

-$138.52M

Year Range

$1.64 - $5.34

Target Price

$7.61

Short %

10.73%

Short Ratio

8.79

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
GERN vs. KIND GERN vs. ADCT GERN vs. SCHD GERN vs. LIN GERN vs. LXRX GERN vs. ABBV GERN vs. UHS GERN vs. MDT GERN vs. RMD GERN vs. VKTX
Popular comparisons:
GERN vs. KIND GERN vs. ADCT GERN vs. SCHD GERN vs. LIN GERN vs. LXRX GERN vs. ABBV GERN vs. UHS GERN vs. MDT GERN vs. RMD GERN vs. VKTX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Geron Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-21.19%
6.74%
GERN (Geron Corporation)
Benchmark (^GSPC)

Returns By Period

Geron Corporation had a return of 0.85% year-to-date (YTD) and 70.81% in the last 12 months. Over the past 10 years, Geron Corporation had an annualized return of 1.36%, while the S&P 500 had an annualized return of 11.51%, indicating that Geron Corporation did not perform as well as the benchmark.


GERN

YTD

0.85%

1M

-10.75%

6M

-21.19%

1Y

70.81%

5Y*

22.43%

10Y*

1.36%

^GSPC (Benchmark)

YTD

1.03%

1M

-2.37%

6M

6.74%

1Y

26.74%

5Y*

12.96%

10Y*

11.51%

*Annualized

Monthly Returns

The table below presents the monthly returns of GERN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-12.80%8.70%65.00%19.09%-9.67%19.44%11.79%0.21%-4.42%-9.47%0.24%-14.08%67.77%
202336.36%-15.76%-21.94%13.36%32.93%-1.83%0.93%-25.00%-12.76%-10.38%1.58%9.33%-12.81%
2022-8.20%-2.68%24.77%3.68%-2.13%12.32%22.58%38.95%-11.36%-5.13%4.50%4.31%98.36%
202111.95%0.56%-11.73%-8.23%-4.83%2.17%-13.48%18.85%-5.52%12.41%-3.90%-17.57%-23.27%
2020-3.68%-12.21%3.48%0.00%35.29%35.40%-27.06%28.93%-15.12%0.00%7.18%-14.75%16.91%
201915.00%26.96%13.70%9.64%-20.33%-2.76%-14.89%16.67%-5.00%7.52%-0.00%-4.90%36.00%
201836.11%-5.71%83.98%-12.47%8.87%-15.31%4.66%59.61%-69.28%-13.07%5.23%-37.89%-44.44%
20170.48%3.37%5.58%12.78%3.91%4.14%-4.33%-18.11%0.46%3.21%-11.56%-9.55%-13.04%
2016-36.98%-20.98%21.16%1.03%0.34%-9.46%-0.00%0.37%-15.99%-18.14%10.27%1.47%-57.23%
2015-2.15%-5.03%24.83%-3.98%6.63%10.88%-5.37%-25.19%-8.91%25.72%46.97%-5.10%48.92%
20145.91%-5.28%-56.05%-5.27%5.05%54.33%-20.71%-1.04%-15.97%11.50%65.02%-11.68%-27.43%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 81, GERN is among the top 19% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of GERN is 8181
Overall Rank
The Sharpe Ratio Rank of GERN is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of GERN is 8989
Sortino Ratio Rank
The Omega Ratio Rank of GERN is 8484
Omega Ratio Rank
The Calmar Ratio Rank of GERN is 7676
Calmar Ratio Rank
The Martin Ratio Rank of GERN is 8383
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Geron Corporation (GERN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for GERN, currently valued at 0.70, compared to the broader market-4.00-2.000.002.000.702.08
The chart of Sortino ratio for GERN, currently valued at 2.59, compared to the broader market-4.00-2.000.002.004.002.592.78
The chart of Omega ratio for GERN, currently valued at 1.30, compared to the broader market0.501.001.502.001.301.38
The chart of Calmar ratio for GERN, currently valued at 0.80, compared to the broader market0.002.004.006.000.803.10
The chart of Martin ratio for GERN, currently valued at 5.34, compared to the broader market0.005.0010.0015.0020.0025.005.3413.27
GERN
^GSPC

The current Geron Corporation Sharpe ratio is 0.70. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Geron Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
0.70
2.08
GERN (Geron Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Geron Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-94.59%
-2.43%
GERN (Geron Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Geron Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Geron Corporation was 98.65%, occurring on Mar 18, 2020. The portfolio has not yet recovered.

The current Geron Corporation drawdown is 94.59%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.65%Mar 2, 20005043Mar 18, 2020
-76.56%Jan 9, 1997415Aug 31, 1998348Jan 18, 2000763
-25.52%Oct 18, 199617Nov 11, 199627Dec 23, 199644
-21.91%Jan 25, 20004Jan 28, 20007Feb 8, 200011
-17.46%Aug 7, 19967Aug 15, 199639Oct 10, 199646

Volatility

Volatility Chart

The current Geron Corporation volatility is 10.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
10.75%
4.36%
GERN (Geron Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Geron Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Geron Corporation.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab